IDiyas

For the Inventor, By the Inventor

Chesterfield, MO, United States of America

David B Reitz

USPTO Granted Patents = 56 

 

Average Co-Inventor Count = 2.3

ph-index = 11

Forward Citations = 587(Granted Patents)

Forward Citations (Not Self Cited) = 578(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • St. Louis, MO (US) (1987 - 1989)
  • Kennett Square, PA (US) (1997)
  • Chesterfield, MO (US) (1992 - 2010)

Company Filing History:

goldMedal41 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal5 out of 200 
 
Pharmacia Corporation
 patents
bronzeMedal2 out of 3,288 
 
Monsanto Company
 patents
4. 1 out of 6 
 
C. D. Searle & Co.
 patents
5. 1 out of 4,455 
 
Pfizer Corporation
 patents
6. 1 out of 33 
 
G.d. Searle LLC
 patents
7. 1 out of 2,538 
 
Warner-lambert Company
 patents
8. 4 out of 832,680 
Other
 patents

Years Active: 1987-2010

Loading Chart...
Loading Chart...
56 patents (USPTO):Explore Patents
1. 7781428 - Pyrazoline compounds (2010-08-24),
2. 7132437 - Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension (2006-11-07),
3. 7119094 - Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade (2006-10-10),
4. 7030153 - 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents (2006-04-18),
5. 6908919 - Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade (2005-06-21),
6. 6875877 - Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides (2005-04-05),
7. 6858636 - 1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders (2005-02-22),
8. 6828338 - Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade (2004-12-07),
9. 6784201 - Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake (2004-08-31),
10. 6677488 - Substituted biphenyl compounds for the treatment of inflammation (2004-01-13),
11. 6664255 - Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade (2003-12-16),
12. 6630497 - 1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders (2003-10-07),
13. 6624180 - Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade (2003-09-23),
14. 6599934 - 3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents (2003-07-29),
15. 6492413 - 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents (2002-12-10),

Sure, I can help with that. Here is an article about inventor David B Reitz:

Title: The Inventive Mind of David B Reitz

Introduction:

David B Reitz, a prolific inventor hailing from Chesterfield, MO (US), has made significant contributions to the field of pharmaceuticals with his innovative patents and research endeavors.

Latest Patents:

David B Reitz holds an impressive number of 54 patents. His recent patents include groundbreaking inventions such as Pyrazoline compounds and Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for the treatment of hypertension. These patents showcase his ingenuity and commitment to developing novel solutions in the pharmaceutical industry.

Career Highlights:

Throughout his career, David B Reitz has worked at renowned companies such as G.D. Searle & Company and Pharmacia Corporation. His tenure at these esteemed organizations has provided him with the platform to explore his innovative ideas and bring them to fruition through pioneering research and development efforts.

Collaborations:

During his professional journey, David B Reitz has had the privilege of working alongside accomplished individuals in the field. Some of his notable coworkers include Robert E Manning and Jinglin J Li. Through collaboration and teamwork, they have collectively advanced the boundaries of scientific discovery and pharmaceutical innovation.

Conclusion:

In conclusion, David B Reitz stands as a testament to the power of innovation and perseverance in the realm of patent inventions. His remarkable portfolio of patents, coupled with his collaborations and career achievements, solidify his status as a visionary inventor shaping the future of pharmaceutical advancements.

If you have any more requests or need further information on inventors, patents, or innovations, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…